TER Teradyne

Q2 2025 10-Q

Filed: Aug 1, 2025Period ending Jun 29, 2025

Health Care

Instruments For Meas & Testing of Electricity & Elec SignalsSEC EDGAR

Teradyne (TER) 10-Q quarterly report for Q2 2025, filed with SEC EDGAR on Aug 1, 2025 for the fiscal period ending Jun 29, 2025. This page provides AI-powered analysis including management discussion & analysis (MD&A), risk factor updates, and key quarterly financial data such as revenue and net income extracted from XBRL.

AI Filing Analysis
Q2 2025 10-Q

Risk Factors

• No new risk factors added this quarter; critical accounting policies unchanged from 2024 10-K
• Most materially updated risk: Semiconductor Test revenue decline 12.1% QoQ due to memory market weakness

+3 more insights

Quarterly Financial Summary
XBRL

Revenue

$652M

▼ -10.7% YoY▼ -4.9% QoQ

Net Income

$78M

▼ -57.9% YoY▼ -20.8% QoQ

Net Margin

12.0%

▼ -1350bp YoY▼ -240bp QoQ

Source: XBRL data from Teradyne Q2 2025 10-Q filing on SEC EDGAR. All figures in USD.

Other Teradyne Quarterly Reports

Q3 2025 10-Q

Q1 2025 10-Q

Get deeper insights on Teradyne

Access full AI analysis, insider trading data, fund holdings, and cross-signal detection on SignalX.